Initial clinical experience with 18F-JK-PSMA-7 PET-CT in evaluation of staging and biochemical recurrence of prostate carcinoma.

被引：0
|
作者：
Chandra, P. [1 ]
Chinnappan, S. [1 ]
Chandran, G. [1 ]
Abraham, C. L. [1 ]
机构：
[1] Zydus Hosp, Vadodara, India
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0821
引用
收藏
页码：S757 / S758
页数：2
相关论文
共 50 条
  • [41] Role of 18F-FDG PET-CT in initial staging of hepatocellular carcinoma and its impact on changing clinical decision
    Abdelhalim, Heba
    Houseni, Mohamed
    Elsakhawy, Mahmoud
    Abd Elbary, Naser
    Elabd, Osama
    EGYPTIAN LIVER JOURNAL, 2020, 10 (01)
  • [42] High detection sensitivity in [18F]PSMA-1007 PET: initial experience focusing on biochemical recurrence in prostate cancer patients
    Watabe, T.
    Uemura, M.
    Soeda, F.
    Naka, S.
    Sasaki, H.
    Kamiya, T.
    Shimosegawa, E.
    Kato, H.
    Nonomura, N.
    Giesel, F. L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S365 - S366
  • [43] The role of 68Ga-PSMA-PET/CT after a negative 18F-Chohne PET/CT in biochemical relapse of prostate cancer: Initial experience
    Dhomps, Anthony
    Tordo, Jaramie
    Sotlar, William
    Hallouard, Franaois
    Darcissac, Caroline
    Fraysse, Marc
    Skanjeti, Andrea
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [44] 68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CT
    Bluemel, Christina
    Krebs, Markus
    Polat, Buelent
    Linke, Fraenze
    Eiber, Matthias
    Samnick, Samuel
    Lapa, Constantin
    Lassmann, Michael
    Riedmiller, Hubertus
    Czernin, Johannes
    Rubello, Domenico
    Bley, Thorsten
    Kropf, Saskia
    Wester, Hans-Juergen
    Buck, Andreas K.
    Herrmann, Ken
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (07) : 515 - 521
  • [45] PRIMARY METASTASIS STAGING USING 18F-PSMA-1007 PET-CT IN HIGH-RISK PROSTATE CANCER
    Anttinen, Mikael
    Ettala, Otto
    Malaspina, Simona
    Jambor, Ivan
    Sandell, Minna
    Kajander, Sami
    Rinta-Kiikka, Irina
    Schildt, Jukka
    Saukko, Ekaterina
    Rautio, Pentti
    Timonen, Kirsi L.
    Noponen, Tommi
    Saunavaara, Jani
    Loyttyniemi, Eliisa
    Taimen, Pekka
    Kemppainen, Jukka
    Dean, Peter B.
    Blanco, Roberto Sequeiros
    Aronen, Hannu J.
    Seppanen, Marko
    Bostrom, Peter J.
    JOURNAL OF UROLOGY, 2020, 203 : E952 - E952
  • [46] [18F]F-DCFPyL-PSMA PET-CT performing dynamic early pelvic acquisition in patients(p) with biochemical recurrence (BR) of Prostate Cancer (PCa): Clinical impact
    Menendez-Sanchez, S.
    Dellepiane-Clarke, F.
    Navales-Mateu, I.
    Cardozo-Saavedra, A.
    Aguade, S.
    Simo, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S289 - S289
  • [47] Diagnostic accuracy and therapeutic impact of [18F] DCFPyL (PSMA) PET/CT in biochemical recurrence of prostate cancer
    Fernandez, J. Fernandez
    Ibanez, E. Trivino
    Solero, T. Rudolphi
    Navas, D. Rivas
    Fernandez, A. Rodriguez
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S291 - S291
  • [48] Impact of [18F]PSMA-1007 PET/CT on management of biochemical recurrence and high-risk staging of prostate cancer patients: A UK single centre experience
    Korolewicz, J.
    Banerjee, D.
    Kimura, M.
    Kulshrestha, R.
    Challapalli, A.
    CLINICAL ONCOLOGY, 2025, 38
  • [49] Clinical utility of F-18 FDG PET-CT in the initial evaluation of lung cancer
    Poul Henning Madsen
    Paw Christian Holdgaard
    Janne Buck Christensen
    Poul Flemming Høilund-Carlsen
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 2084 - 2097
  • [50] Comparison of 18F-FDG and 68Ga-PSMA PET-CT for evaluation of hepatocellular carcinoma
    Shamim, S.
    Kumar, N.
    Arora, G.
    Gamanagatti, S.
    Shalimar
    Bal, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S375 - S375
12345